These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1879964)

  • 1. Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
    Washitani Y; Kuroda N; Shiraki H; Nishimura Y; Yamaguchi K; Takatsuki K; Fernando LP; Fang CT; Kiyokawa H; Maeda Y
    Int J Cancer; 1991 Sep; 49(2):173-7. PubMed ID: 1879964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
    Lal RB; Rudolph DL; Lairmore MD; Khabbaz RF; Garfield M; Coligan JE; Folks TM
    J Infect Dis; 1991 Jan; 163(1):41-6. PubMed ID: 1984475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
    Viscidi RP; Hill PM; Li SJ; Cerny EH; Vlahov D; Farzadegan H; Halsey N; Kelen GD; Quinn TC
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1190-8. PubMed ID: 1941526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
    Kuroda N; Washitani Y; Shiraki H; Kiyokawa H; Ohno M; Sato H; Maeda Y
    Int J Cancer; 1990 May; 45(5):865-8. PubMed ID: 2185995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.
    Washitani Y; Kuroda N; Shiraki H; Itoyama Y; Sato H; Ohshima K; Kiyokawa H; Maeda Y
    J Clin Microbiol; 1992 Feb; 30(2):287-90. PubMed ID: 1537894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
    Bocalandro YM; Marin MH; Vallejo RA; Peña LP; León CS; Martínez GR; Tanty CR; Clarke DH; Velázquez SB
    J Immunoassay Immunochem; 2004; 25(3):205-14. PubMed ID: 15461383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Evaluation of a Novel ELISA for Detection of Antibodies against HTLV-I Using Chimeric Peptides.
    Mosadeghi P; Heydari-Zarnagh H
    Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):144-150. PubMed ID: 29757587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins.
    Rudolph DL; Khabbaz RF; Folks TM; Lal RB
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):35-9. PubMed ID: 8102953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.
    Aboulafia DM; Bennett C; Koga H; Keith D; Slamon D
    Viral Immunol; 1992; 5(2):105-11. PubMed ID: 1616582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
    Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
    Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.
    Yamada K; Kuroda N; Washitani Y; Shiraki H; Maeda Y
    Clin Chem; 1992 May; 38(5):699-703. PubMed ID: 1582023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins.
    Rudolph DL; Lal RB
    Clin Chem; 1993 Feb; 39(2):288-92. PubMed ID: 7679339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
    Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.